These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2944913)

  • 1. The effects of naltrexone, an oral beta-endorphin antagonist, in children with the Prader-Willi syndrome.
    Zlotkin SH; Fettes IM; Stallings VA
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1229-32. PubMed ID: 2944913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of abnormal food-intake patterns in children with Prader-Willi syndrome and study of effects of naloxone.
    Zipf WB; Berntson GG
    Am J Clin Nutr; 1987 Aug; 46(2):277-81. PubMed ID: 3618531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome.
    Tan TM; Vanderpump M; Khoo B; Patterson M; Ghatei MA; Goldstone AP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4162-5. PubMed ID: 15292365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-endorphin immunoreactivity in the plasma of patients with the Prader-Labhart-Willi syndrome and their normal siblings.
    Margules DL; Inturrisi CE
    Experientia; 1983 Jul; 39(7):766-7. PubMed ID: 6305703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prader-Willi Syndrome, Management of Impulsivity, and Hyperphagia in an Adolescent.
    Puri MR; Sahl R; Ogden S; Malik S
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):403-4. PubMed ID: 27028699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone and fluoxetine in Prader-Willi syndrome.
    Benjamin E; Buot-Smith T
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):870-3. PubMed ID: 8340312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of naltrexone for treating pathologic skin picking behavior in an adolescent with Prader-Willi syndrome.
    Banga A; Connor DF
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):396-8. PubMed ID: 23083028
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children.
    Ernst M; Devi L; Silva RR; Gonzalez NM; Small AM; Malone RP; Campbell M
    Psychopharmacol Bull; 1993; 29(2):221-7. PubMed ID: 8290669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Naltrexone/Bupropion Combination Treatment on Body Mass Index in Prader-Willi Syndrome Re: "Prader-Willi Syndrome, Management of Impulsivity, and Hyperphagia in an Adolescent" by Puri et al.
    Hor A; Purtell L
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):854. PubMed ID: 27768385
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.
    Sze L; Purtell L; Jenkins A; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1314-9. PubMed ID: 21632815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial of naltrexone in premenstrual syndrome.
    Chuong CJ; Coulam CB; Bergstralh EJ; O'Fallon WM; Steinmetz GI
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):332-6. PubMed ID: 3043289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the opiate antagonist, naltrexone, on binging antecedents and plasma beta-endorphin concentrations.
    Chatoor I; Herman BH; Hartzler J
    J Am Acad Child Adolesc Psychiatry; 1994 Jun; 33(5):748-52. PubMed ID: 8056738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prader-Willi syndrome: a study of 40 patients and a review of the literature.
    Bray GA; Dahms WT; Swerdloff RS; Fiser RH; Atkinson RL; Carrel RE
    Medicine (Baltimore); 1983 Mar; 62(2):59-80. PubMed ID: 6338343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rett syndrome: controlled study of an oral opiate antagonist, naltrexone.
    Percy AK; Glaze DG; Schultz RJ; Zoghbi HY; Williamson D; Frost JD; Jankovic JJ; del Junco D; Skender M; Waring S
    Ann Neurol; 1994 Apr; 35(4):464-70. PubMed ID: 8154874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone therapy of apnea in children with elevated cerebrospinal fluid beta-endorphin.
    Myer EC; Morris DL; Brase DA; Dewey WL; Zimmerman AW
    Ann Neurol; 1990 Jan; 27(1):75-80. PubMed ID: 2137320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity levels of persons with Prader-Willi syndrome.
    Nardella MT; Sulzbacher SI; Worthington-Roberts BS
    Am J Ment Defic; 1983 Mar; 87(5):498-505. PubMed ID: 6837640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone.
    Scifo R; Cioni M; Nicolosi A; Batticane N; Tirolo C; Testa N; Quattropani MC; Morale MC; Gallo F; Marchetti B
    Ann Ist Super Sanita; 1996; 32(3):351-9. PubMed ID: 9028057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome.
    Haqq AM; Stadler DD; Jackson RH; Rosenfeld RG; Purnell JQ; LaFranchi SH
    J Clin Endocrinol Metab; 2003 May; 88(5):2206-12. PubMed ID: 12727976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of opioid antagonists in the treatment of obesity. Results of a clinical trial with naltrexone].
    Novi RF; Lamberto M; Visconti P; Maurino M; Ardizzone A; Mantovan M; Meluzzi A; Francesetti G; Molinatti GM
    Minerva Endocrinol; 1990; 15(2):121-3. PubMed ID: 2098653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prader-Willi syndrome: medical, emotional and cognitive facets].
    Gross-Tsur V; Landau YE
    Harefuah; 2000 May; 138(10):833-6, 910. PubMed ID: 10883249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.